These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11140432

  • 1. Comparison of the systemic availability of fluticasone propionate in healthy volunteers and patients with asthma.
    Daley-Yates PT, Tournant J, Kunka RL.
    Clin Pharmacokinet; 2000; 39 Suppl 1():39-45. PubMed ID: 11140432
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in patients with mild-to-moderate asthma.
    Falcoz C, Horton J, Mackie AE, Harding SM, Daley-Yates PT.
    Clin Pharmacokinet; 2000; 39 Suppl 1():31-7. PubMed ID: 11140431
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of fluticasone propionate inhaled via the Diskhaler and Diskus powder devices in healthy volunteers.
    Mackie AE, McDowall JE, Falcoz C, Ventresca P, Bye A, Daley-Yates PT.
    Clin Pharmacokinet; 2000; 39 Suppl 1():23-30. PubMed ID: 11140430
    [Abstract] [Full Text] [Related]

  • 4. The relationship between systemic exposure to fluticasone propionate and cortisol reduction in healthy male volunteers.
    Mackie AE, Bye A.
    Clin Pharmacokinet; 2000; 39 Suppl 1():47-54. PubMed ID: 11140433
    [Abstract] [Full Text] [Related]

  • 5. Single-dose and steady-state pharmacokinetic and pharmacodynamic evaluation of therapeutically clinically equivalent doses of inhaled fluticasone propionate and budesonide, given as Diskus or Turbohaler dry-powder inhalers to healthy subjects.
    Möllmann H, Wagner M, Krishnaswami S, Dimova H, Tang Y, Falcoz C, Daley-Yates PT, Krieg M, Stöckmann R, Barth J, Lawlor C, Möllmann AC, Derendorf H, Hochhaus G.
    J Clin Pharmacol; 2001 Dec; 41(12):1329-38. PubMed ID: 11762560
    [Abstract] [Full Text] [Related]

  • 6. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study.
    Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, Brown R, Custovic A, Woodcock A.
    Lancet; 2000 Aug 12; 356(9229):556-61. PubMed ID: 10950233
    [Abstract] [Full Text] [Related]

  • 7. Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate.
    Rohatagi S, Bye A, Falcoz C, Mackie AE, Meibohm B, Möllmann H, Derendorf H.
    J Clin Pharmacol; 1996 Oct 12; 36(10):938-41. PubMed ID: 8930781
    [Abstract] [Full Text] [Related]

  • 8. Relative lung delivery of fluticasone propionate via large volume spacer or nebuliser in healthy volunteers.
    Dempsey OJ, Humphreys M, Coutie WJ, Lipworth BJ.
    Eur J Clin Pharmacol; 2001 Nov 12; 57(9):637-41. PubMed ID: 11791892
    [Abstract] [Full Text] [Related]

  • 9. Systemic exposure and urinary cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma.
    Kim KT, Milgrom H, Yoon YK, Levy AL, Matz P, Welch MJ, Cahn A, Collins DA, Kathman S, Mehta R, Su SF, Kunka RL.
    J Clin Pharmacol; 2008 Jan 12; 48(1):108-16. PubMed ID: 18094223
    [Abstract] [Full Text] [Related]

  • 10. Nocturnal cortisol secretion in asthmatic patients after inhalation of fluticasone propionate.
    Weiner P, Berar-Yanay N, Davidovich A, Magadle R.
    Chest; 1999 Oct 12; 116(4):931-4. PubMed ID: 10531155
    [Abstract] [Full Text] [Related]

  • 11. Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects.
    Harrison TW, Tattersfield AE.
    Thorax; 2003 Mar 12; 58(3):258-60. PubMed ID: 12612308
    [Abstract] [Full Text] [Related]

  • 12. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
    Mackie AE, McDowall JE, Ventresca P, Bye A, Falcoz C, Daley-Yates PT.
    Clin Pharmacokinet; 2000 Mar 12; 39 Suppl 1():17-22. PubMed ID: 11140429
    [Abstract] [Full Text] [Related]

  • 13. Absorption kinetics after inhalation of fluticasone propionate via the Diskhaler, Diskus and metered-dose inhaler in healthy volunteers.
    Brindley C, Falcoz C, Mackie AE, Bye A.
    Clin Pharmacokinet; 2000 Mar 12; 39 Suppl 1():1-8. PubMed ID: 11140428
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT, Mehta R, Chan RH, Despa SX, Louey MD.
    J Aerosol Med Pulm Drug Deliv; 2014 Aug 12; 27(4):279-89. PubMed ID: 24074143
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
    Dempsey OJ, Wilson AM, Coutie WJ, Lipworth BJ.
    Chest; 1999 Oct 12; 116(4):935-40. PubMed ID: 10531156
    [Abstract] [Full Text] [Related]

  • 16. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.
    Nair A, Menzies D, Hopkinson P, McFarlane L, Lipworth BJ.
    Br J Clin Pharmacol; 2009 Feb 12; 67(2):191-8. PubMed ID: 19220273
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of epimeric budesonide and fluticasone propionate after repeat dose inhalation--intersubject variability in systemic absorption from the lung.
    Minto C, Li B, Tattam B, Brown K, Seale JP, Donnelly R.
    Br J Clin Pharmacol; 2000 Aug 12; 50(2):116-24. PubMed ID: 10930963
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic and pharmacodynamic evaluation of fluticasone propionate after inhaled administration.
    Möllmann H, Wagner M, Meibohm B, Hochhaus G, Barth J, Stöckmann R, Krieg M, Weisser H, Falcoz C, Derendorf H.
    Eur J Clin Pharmacol; 1998 Feb 12; 53(6):459-67. PubMed ID: 9551705
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
    Gillespie M, Song S, Steinfeld J.
    Allergy Asthma Proc; 2015 Feb 12; 36(5):365-71. PubMed ID: 26314817
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects.
    Thorsson L, Dahlström K, Edsbäcker S, Källén A, Paulson J, Wirén JE.
    Br J Clin Pharmacol; 1997 Feb 12; 43(2):155-61. PubMed ID: 9131947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.